|
US8232242B2
(en)
|
|
Treatment of inflammatory bowel diseases with mammal beta defensins
|
|
EP2320929B1
(en)
|
|
Human beta defensins for use in the treatment of inflammatory diseases
|
|
Zaiou et al.
|
|
Cathelicidins, essential gene-encoded mammalian antibiotics |
|
Guaní-Guerra et al.
|
|
Antimicrobial peptides: general overview and clinical implications in human health and disease |
|
US9833495B2
(en)
|
|
Oral treatment of inflammatory bowel disease
|
|
EP2320928B1
(en)
|
|
Treatment of rheumatoid arthritis with human beta defensins
|
|
HK1164735A
(zh)
|
|
使用哺乳动物β防御素的炎性肠病的治疗
|
|
AU2011203033A1
(en)
|
|
Treatment of inflammatory bowel diseases with mammal beta defensins
|
|
Class et al.
|
|
Patent application title: Treatment Of Rheumatoid Arthritis With Mammal Beta Defensins Inventors: Tanja Maria Rosenkilde Kjaer (Holte, DK) Tanja Maria Rosenkilde Kjaer (Holte, DK) Thomas Kruse (Copenhagen N, DK) Per Holse Mygind (Vaerloese, DK) Per Holse Mygind (Vaerloese, DK) Karoline Sidelmann Brinch (Copenhagen Nv, DK) Karoline Sidelmann Brinch (Copenhagen Nv, DK) Soeren Kjaerulff (Holte, DK) Birgitte Andersen (Bagsvaerd, DK) Birgitte Andersen (Bagsvaerd, DK) Assignees: Novozymes A/S |